Template:Lactic acidosis DDX: Difference between revisions

 
Line 31: Line 31:
*Malignancy
*Malignancy
*Exercise
*Exercise
*[[Albuterol]] and other beta agonists<ref>Dodda V and Spiro P. Albuterol, an Uncommonly Recognized Culprit in Lactic Acidosis. Chest. 2011;140.</ref>
*[[Albuterol]] and other beta agonists<ref>Dodda V and Spiro P. Albuterol, an Uncommonly Recognized Culprit in Lactic Acidosis. Chest. 2011;140.</ref><ref>. Zitek T, Cleveland N, Rahbar A, et al. Effect of nebulized albuterol
on serum lactate and potassium in healthy subjects. Acad Emerg
Med 2016;23:718–21.</ref>
*Toxicologic Causes:
*Toxicologic Causes:
**[[Cyanide]]
**[[Cyanide]]

Latest revision as of 01:15, 7 March 2021

Lactic acidosis

By Type

  • Type A (tissue hypoperfusion)
  • Type B (decreased utilization)
  • Type D
    • episodes of encephalopathy and metabolic acidosis typically following high carbohydrate meals in patients with short bowel syndrome
    • metabolic acidosis and high serum anion gap, normal lactate level, short bowel syn or other forms of malabsorption, and characteristic neurologic findings
      • Type D lactate is not detected with standard lactate levels

Complete List

  1. Dodda V and Spiro P. Albuterol, an Uncommonly Recognized Culprit in Lactic Acidosis. Chest. 2011;140.
  2. . Zitek T, Cleveland N, Rahbar A, et al. Effect of nebulized albuterol on serum lactate and potassium in healthy subjects. Acad Emerg Med 2016;23:718–21.